Overview

Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes

Status:
Unknown status

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this trial is to study the efficacy and safety of pioglitazone added to combination therapy of sulfonylurea plus metformin with placebo in patients with type 2 diabetes.

Phase:

Phase 4

Details

Lead Sponsor:

National Cheng-Kung University Hospital

Treatments:

Metformin
Pioglitazone